Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-06-26)
Last
 11.24
Change
 ⇑ +1.01   (+9.87%)
Volume
  7,015,745
Open
 10.75
High
 11.54
Low
 10.43
8EMA (Daily)
 10.91
40EMA (Daily)
 10.36
50EMA (Daily)
 10.16
STO (Daily)
 15.820
MACD Hist (Daily)
 -0.429
8EMA (Weekly)
 10.560
40EMA (Weekly)
 9.91
50EMA (Weekly)
 9.65
STO (Weekly)
 70.593
MACD Hist (Weekly)
 0.693
Stellar Biotechnologies Inc is a biotechnology company. The company is engaged in the aquaculture, research, and development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein with an extensive history of safe and effective use in immunological applications. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a variety of diseases. It derives its revenues mostly from Europe. Stellar primarily market and distribute products directly to biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com